Literature DB >> 23889949

Novel pharmacologic treatment attenuates septic shock and improves long-term survival.

Ting Zhao1, Yongqing Li, Baoling Liu, Zhengcai Liu, Wei Chong, Xiuzhen Duan, Danielle K Deperalta, George C Velmahos, Hasan B Alam.   

Abstract

BACKGROUND: We have demonstrated previously that suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, improves survival in a lipopolysaccharide-induced lethal model of endotoxemia. The goal of this study was to investigate the impact of SAHA on survival in a more clinically relevant model of cecal ligation and puncture (CLP)-induced septic shock and to elucidate changes in cytokine responses and organ injury.
METHODS: C57BL/6J mice were subjected to CLP, and 1 hour later were given intraperitoneally either SAHA dissolved in dimethyl sulfoxide or dimethyl sulfoxide only. Survival was monitored for 10 days. In a second study, livers were harvested for evaluation of acute liver injury, and peritoneal fluid and blood samples were collected for cytokine assays. In addition, RAW264.7 and bone marrow-derived macrophages were used to assess effects of SAHA on cytokine responses.
RESULTS: SAHA-treated animals displayed a substantial improvement in survival. In addition, SAHA also attenuated cytokine levels in blood and peritoneal fluid compared with vehicle animals, as well as in culture supernatant of macrophages stimulated with bacterial components (lipopolysaccharide or Pam3CSK4). Moreover, SAHA-treated animals showed a substantial decrease in acute liver injury.
CONCLUSION: SAHA treatment improves survival, decreases "cytokine storm," and prevents distant organ damage in a lethal septic model.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23889949      PMCID: PMC4361041          DOI: 10.1016/j.surg.2013.04.003

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

Review 1.  TLR signaling pathways.

Authors:  Kiyoshi Takeda; Shizuo Akira
Journal:  Semin Immunol       Date:  2004-02       Impact factor: 11.130

Review 2.  HDACi: molecular mechanisms and therapeutic implications in the innate immune system.

Authors:  Bandar Ali Suliman; Dakang Xu; Bryan R G Williams
Journal:  Immunol Cell Biol       Date:  2011-11-15       Impact factor: 5.126

3.  Acetylation of Stat1 modulates NF-kappaB activity.

Authors:  Oliver H Krämer; Daniela Baus; Shirley K Knauer; Stefan Stein; Elke Jäger; Roland H Stauber; Manuel Grez; Edith Pfitzner; Thorsten Heinzel
Journal:  Genes Dev       Date:  2006-02-15       Impact factor: 11.361

4.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

5.  Bone Marrow-Derived Macrophages (BMM): Isolation and Applications.

Authors:  Joachim Weischenfeldt; Bo Porse
Journal:  CSH Protoc       Date:  2008-12-01

6.  Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.

Authors:  Heike Weighardt; Gabriela Jusek; Jörg Mages; Roland Lang; Kasper Hoebe; Bruce Beutler; Bernhard Holzmann
Journal:  Eur J Immunol       Date:  2004-02       Impact factor: 5.532

7.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

8.  Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.

Authors:  Wei Chong; Yongqing Li; Baoling Liu; Ting Zhao; Eugene Y Fukudome; Zhengcai Liu; William M Smith; George C Velmahos; Marc A deMoya; Hasan B Alam
Journal:  J Surg Res       Date:  2012-07-26       Impact factor: 2.192

9.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Young-Jun Park; Yuko Tsuruta; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

10.  Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses.

Authors:  Akihiro Kimura; Tetsuji Naka; Taisuke Nakahama; Ichino Chinen; Kazuya Masuda; Keiko Nohara; Yoshiaki Fujii-Kuriyama; Tadamitsu Kishimoto
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more
  27 in total

1.  Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Erxi Wu; Martin Sillesen; George C Velmahos; Ihab Halaweish; Hasan B Alam
Journal:  Surgery       Date:  2014-06-21       Impact factor: 3.982

Review 2.  Creating a "Prosurvival Phenotype" Through Histone Deacetylase Inhibition: Past, Present, and Future.

Authors:  Ihab Halaweish; Vahagn Nikolian; Patrick Georgoff; Yongqing Li; Hasan B Alam
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

3.  Citrullinated histone H3: a novel target for the treatment of sepsis.

Authors:  Yongqing Li; Zhengcai Liu; Baoling Liu; Ting Zhao; Wei Chong; Yanming Wang; Hasan B Alam
Journal:  Surgery       Date:  2014-06-21       Impact factor: 3.982

4.  Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.

Authors:  Yongqing Li; Ting Zhao; Baoling Liu; Ihab Halaweish; Ralph Mazitschek; Xiuzhen Duan; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2015-02       Impact factor: 3.313

5.  Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Ihab Halaweish; Ralph Mazitschek; Hasan B Alam
Journal:  J Surg Res       Date:  2014-02-04       Impact factor: 2.192

Review 6.  Histone Deacetylase Inhibitors: A Novel Strategy in Trauma and Sepsis.

Authors:  Aaron M Williams; Isabel S Dennahy; Umar F Bhatti; Ben E Biesterveld; Nathan J Graham; Yongqing Li; Hasan B Alam
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

7.  The Effects of Molecular Hydrogen and Suberoylanilide Hydroxamic Acid on Paraquat-Induced Production of Reactive Oxygen Species and TNF-α in Macrophages.

Authors:  Jiaoyang Li; Xizi Wu; Yao Chen; Renqing Zeng; Yangzi Zhao; Panpan Chang; Danna Wang; Qianwen Zhao; Yunlei Deng; Yongqing Li; Hasan B Alam; Wei Chong
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

8.  Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Baihong Pan; Xin Cheng; Patrick Georgoff; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2016-01       Impact factor: 3.313

9.  Histone deacetylase inhibitors decrease intra-abdominal adhesions with one intraoperative dose by reducing peritoneal fibrin deposition pathways.

Authors:  Michael R Cassidy; Alan C Sherburne; Holly K Sheldon; Melanie L Gainsbury; Stanley Heydrick; Arthur F Stucchi
Journal:  Surgery       Date:  2013-11-14       Impact factor: 3.982

10.  Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsis.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Roderick T Bronson; Ihab Halaweish; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.